Parkinson’s Disease Treatment Market By Treatment Type (Surgical Treatments {Deep Brain Stimulation (DBS) and Lesioning procedures}, Non-Surgical Treatments {Medications [Dopaminergic medications, MAO-B inhibitors, COMT inhibitors, Anticholinergics, and Amantadine] and Supportive Therapies [Physical therapy, Occupational therapy, and Speech therapy]}, and Others), By Route of Administration (Oral, Injectable, Transdermal, and Inhalable), By Disease Stage (Stage 1, Stage 2, Stage 3, Stage 4, and Stage 5), and By End-User (Hospitals, Specialty clinics, Home care settings, and Rehabilitation centers), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Treatment Type

• Surgical Treatments
  • Deep Brain Stimulation (DBS)
  • Lesioning procedures
  • Others
• Non-Surgical Treatments
  • Medications
    • Dopaminergic medications
    • MAO-B inhibitors
    • COMT inhibitors
    • Anticholinergics
    • Amantadine
    • Others
  • Supportive Therapies
    • Physical therapy
    • Occupational therapy
    • Speech therapy
    • Others

By Route of Administration

• Oral
• Injectable
• Transdermal
• Inhalation

By Disease Stage

• Stage 1
• Stage 2
• Stage 3
• Stage 4
• Stage 5

By End User

• Hospitals
• Specialty clinics
• Home care settings
• Rehabilitation centers

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• AbbVie Inc.
• Bristol-Myers Squibb
• Teva Pharmaceutical Industries Ltd.
• GlaxoSmithKline plc
• Lundbeck A/S
• Novartis AG
• Amgen Inc.
• Sanofi S.A.
• Neurocrine Biosciences, Inc.
• Roche Holding AG
• Acorda Therapeutics, Inc.
• Otsuka Pharmaceutical Co., Ltd.
• Zambon S.p.A.
• Medtronic plc
• UCB S.A.